Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy
ICD-10 E11.43 is a billable code used to indicate a diagnosis of type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy.
E11.43 refers to Type 2 diabetes mellitus complicated by diabetic autonomic neuropathy, a condition where the autonomic nervous system is affected due to prolonged hyperglycemia. This can lead to various symptoms including gastrointestinal issues, cardiovascular problems, and sexual dysfunction. Patients may experience orthostatic hypotension, gastroparesis, and bladder dysfunction. The diagnosis is typically made based on clinical symptoms, patient history, and diagnostic tests such as nerve conduction studies. Management of this condition involves strict glycemic control, often monitored through HbA1c levels, and may include medications to manage symptoms. Insulin therapy may be required for some patients, especially if oral hypoglycemics are insufficient. Regular monitoring for complications is essential, as autonomic neuropathy can significantly impact quality of life and increase the risk of other diabetic complications.
Detailed records of blood glucose levels, HbA1c results, and treatment plans.
Patients presenting with uncontrolled diabetes and symptoms of neuropathy.
Endocrinologists must document the specific type of neuropathy and its impact on the patient's overall health.
Neurological assessments, nerve conduction studies, and symptom evaluations.
Patients with diabetes presenting with neuropathic symptoms such as pain, numbness, or autonomic dysfunction.
Neurologists should ensure clear documentation of the relationship between diabetes and neuropathy.
Used during routine follow-up visits for diabetes management.
Document patient's diabetes management plan, including HbA1c levels and any neuropathy symptoms.
Endocrinologists should ensure comprehensive documentation of diabetes control and complications.
HbA1c levels are crucial in managing E11.43 as they reflect the patient's average blood glucose control over the past 2-3 months. Maintaining HbA1c levels within target ranges can help prevent further complications associated with diabetic autonomic neuropathy.
